Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Jun 23;11(9):1546–1556. doi: 10.2215/CJN.13121215

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2016 by the American Society of Nephrology

PMC Copyright notice

Figure 1. — Kaplan–Meier survival estimates for the composite outcome stratified by baseline biomarker quartile (log rank chi–squared P value). (A) High–sensitivity C–reactive protein (CRP) and composite outcome (P=0.42). (B) Fibrinogen and composite outcome (P<0.001). (C) IL-1β and composite outcome (P<0.001). (D) IL-1 receptor antagonist (IL-1RA) and composite outcome (P=0.001). (E) IL-6 and composite outcome (P<0.001). (F) TNF-α and composite outcome (P<0.001). (G) TGF-β and composite outcome (P=0.06). (H) Serum albumin and composite outcome (P<0.001). Q, quartile.

Figure 1. — Kaplan–Meier survival estimates for the composite outcome stratified by baseline biomarker quartile (log rank chi–squared P value). (A) High–sensitivity C–reactive protein (CRP) and composite outcome (P=0.42). (B) Fibrinogen and composite outcome (P<0.001). (C) IL-1β and composite outcome (P<0.001). (D) IL-1 receptor antagonist (IL-1RA) and composite outcome (P=0.001). (E) IL-6 and composite outcome (P<0.001). (F) TNF-α and composite outcome (P<0.001). (G) TGF-β and composite outcome (P=0.06). (H) Serum albumin and composite outcome (P<0.001). Q, quartile.